| Frontiers in Cell and Developmental Biology | |
| Leucine-Rich α-2-Glycoprotein 1 Suppresses Endothelial Cell Activation Through ADAM10-Mediated Shedding of TNF-α Receptor | |
| Xiaomeng Wang1  Chee Wai Fhu2  Rui Ning Chia3  Beiying Qiu3  Christina M. Warboys4  Peter D. Weinberg5  Mean Ghim5  Fiona L. Wilkinson6  Ria Weston6  Padmini Sarathchandra7  Magdi H. Yacoub7  Adrian H. Chester7  Kuin Tian Pang8  Chenghao Liu9  Hui Min Tay1,10  Han Wei Hou1,10  | |
| [1] 0Singapore Eye Research Institute, Singapore, Singapore;Cancer Science Institute of Singapore, National University of Singapore, Singapore;Centre for Vision Research, Duke-NUS Medical School, Singapore, Singapore;Comparative Biomedical Sciences, The Royal Veterinary College, London, United Kingdom;Department of Bioengineering, Imperial College London, London, United Kingdom;Department of Life Sciences, Manchester Metropolitan University, Manchester, United Kingdom;Harefield Heart Science Centre, National Heart and Lung Institute, Imperial College London, London, United Kingdom;Institute of Molecular and Cell Biology, Agency for Science, Technology and Research (A∗STAR), Singapore, Singapore;Lee Kong Chian School of Medicine, Nanyang Technological University, Singapore, Singapore;School of Mechanical and Aerospace Engineering, Nanyang Technological University, Singapore, Singapore; | |
| 关键词: leucine-rich α-2-glycoprotein 1; NF-κB; TNFR1 shedding; endothelial activation; coronary artery disease; critical limb ischemia; | |
| DOI : 10.3389/fcell.2021.706143 | |
| 来源: DOAJ | |
【 摘 要 】
Elevated serum concentrations of leucine-rich α-2-glycoprotein (LRG1) have been reported in patients with inflammatory, autoimmune, and cardiovascular diseases. This study aims to investigate the role of LRG1 in endothelial activation. LRG1 in endothelial cells (ECs) of arteries and serum of patients with critical limb ischemia (CLI) was assessed by immunohistochemistry and ELISA, respectively. LRG1 expression in sheared and tumor necrosis factor-α (TNF-α)-treated ECs was analyzed. The mechanistic role of LRG1 in endothelial activation was studied in vitro. Plasma of 37-week-old Lrg1–/– mice was used to investigate causality between LRG1 and tumor necrosis factor receptor 1 (TNFR1) shedding. LRG1 was highly expressed in ECs of stenotic but not normal arteries. LRG1 concentrations in serum of patients with CLI were elevated compared to healthy controls. LRG1 expression was shear dependent. It could be induced by TNF-α, and the induction of its expression was mediated by NF-κB activation. LRG1 inhibited TNF-α-induced activation of NF-κB signaling, expression of VCAM-1 and ICAM-1, and monocyte capture, firm adhesion, and transendothelial migration. Mechanistically, LRG1 exerted its function by causing the shedding of TNFR1 via the ALK5-SMAD2 pathway and the subsequent activation of ADAM10. Consistent with this mechanism, LRG1 and sTNFR1 concentrations were correlated in the serum of CLI patients. Causality between LRG1 and TNFR1 shedding was established by showing that Lrg1–/–mice had lower plasma sTNFR1 concentrations than wild type mice. Our results demonstrate a novel role for LRG1 in endothelial activation and its potential therapeutic role in inflammatory diseases should be investigated further.
【 授权许可】
Unknown